Editorial
doi: 10.2215/CJN.02660707.
Epub 2007 Aug 16.
Do we have a pill for renal fibrosis?
- PMID: 17702718
- DOI: 10.2215/CJN.02660707
Item in Clipboard
Editorial
Do we have a pill for renal fibrosis?
Clin J Am Soc Nephrol.
2007 Sep.
No abstract available
Comment on
-
Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis.Clin J Am Soc Nephrol. 2007 Sep;2(5):906-13. doi: 10.2215/CJN.01050207. Epub 2007 Aug 16. Clin J Am Soc Nephrol. 2007. PMID: 17702727
Similar articles
-
Pirfenidone.IDrugs. 2004 Feb;7(2):166-72. IDrugs. 2004. PMID: 15057662 Review.
-
[Hypertensive heart disease in the patient with chronic kidney disease].Nefrologia. 2008;28(2):135-42. Nefrologia. 2008. PMID: 18454701 Review. Spanish. No abstract available.
-
Extracellular volume and aldosterone interaction in chronic kidney disease.Blood Purif. 2009;27(1):92-8. doi: 10.1159/000167016. Epub 2009 Jan 23. Blood Purif. 2009. PMID: 19169025 Review.
-
Treatment targets in renal fibrosis.Nephrol Dial Transplant. 2007 Dec;22(12):3391-407. doi: 10.1093/ndt/gfm393. Epub 2007 Sep 21. Nephrol Dial Transplant. 2007. PMID: 17890247 Review. No abstract available.
-
Nephrogenic systemic fibrosis: recommendations for gadolinium-based contrast use in patients with kidney disease.Semin Dial. 2008 Mar-Apr;21(2):171-3. doi: 10.1111/j.1525-139X.2007.00402.x. Epub 2008 Jan 23. Semin Dial. 2008. PMID: 18226005 Review.
Cited by
-
MK-2206 Alleviates Renal Fibrosis by Suppressing the Akt/mTOR Signaling Pathway In Vivo and In Vitro.Cells. 2022 Nov 5;11(21):3505. doi: 10.3390/cells11213505. Cells. 2022. PMID: 36359901 Free PMC article.
-
An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis.Acta Pharm Sin B. 2021 Mar;11(3):835-847. doi: 10.1016/j.apsb.2020.10.016. Epub 2020 Oct 18. Acta Pharm Sin B. 2021. PMID: 33777685 Free PMC article.
-
Knockdown of AMPKα2 impairs epithelial‑mesenchymal transition in rat renal tubular epithelial cells by downregulating ETS1 and RPS6KA1.Mol Med Rep. 2020 Dec;22(6):4619-4628. doi: 10.3892/mmr.2020.11556. Epub 2020 Oct 1. Mol Med Rep. 2020. PMID: 33173986 Free PMC article.
-
HL156A, a novel pharmacological agent with potent adenosine-monophosphate-activated protein kinase (AMPK) activator activity ameliorates renal fibrosis in a rat unilateral ureteral obstruction model.PLoS One. 2018 Aug 30;13(8):e0201692. doi: 10.1371/journal.pone.0201692. eCollection 2018. PLoS One. 2018. PMID: 30161162 Free PMC article.
-
Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach.Sci Rep. 2017 Jan 4;7:39487. doi: 10.1038/srep39487. Sci Rep. 2017. PMID: 28051114 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
